South Korea · Delayed Price · Currency is KRW AprilBio Statistics
Total Valuation
AprilBio has a market cap or net worth of KRW 970.50 billion. The enterprise value is 888.00 billion.
| Market Cap | 970.50B |
| Enterprise Value | 888.00B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AprilBio has 23.41 million shares outstanding. The number of shares has increased by 1.41% in one year.
| Current Share Class | 23.41M |
| Shares Outstanding | 23.41M |
| Shares Change (YoY) | +1.41% |
| Shares Change (QoQ) | -3.23% |
| Owned by Insiders (%) | 29.65% |
| Owned by Institutions (%) | 17.91% |
| Float | 16.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,337.98 |
| PB Ratio | 9.91 |
| P/TBV Ratio | 10.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 110.34, with a Debt / Equity ratio of 0.00.
| Current Ratio | 110.34 |
| Quick Ratio | 108.28 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -21.28 |
Financial Efficiency
Return on equity (ROE) is -10.64% and return on invested capital (ROIC) is -6.03%.
| Return on Equity (ROE) | -10.64% |
| Return on Assets (ROA) | -5.85% |
| Return on Invested Capital (ROIC) | -6.03% |
| Return on Capital Employed (ROCE) | -9.53% |
| Weighted Average Cost of Capital (WACC) | 12.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +138.12% in the last 52 weeks. The beta is 1.45, so AprilBio's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | +138.12% |
| 50-Day Moving Average | 56,892.00 |
| 200-Day Moving Average | 47,066.00 |
| Relative Strength Index (RSI) | 34.97 |
| Average Volume (20 Days) | 360,854 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AprilBio had revenue of KRW 725.35 million and -10.12 billion in losses. Loss per share was -449.15.
| Revenue | 725.35M |
| Gross Profit | 701.89M |
| Operating Income | -9.35B |
| Pretax Income | -10.12B |
| Net Income | -10.12B |
| EBITDA | -8.67B |
| EBIT | -9.35B |
| Loss Per Share | -449.15 |
Balance Sheet
The company has 82.94 billion in cash and 440.09 million in debt, with a net cash position of 82.50 billion or 3,523.63 per share.
| Cash & Cash Equivalents | 82.94B |
| Total Debt | 440.09M |
| Net Cash | 82.50B |
| Net Cash Per Share | 3,523.63 |
| Equity (Book Value) | 97.90B |
| Book Value Per Share | 4,383.64 |
| Working Capital | 85.53B |
Cash Flow
In the last 12 months, operating cash flow was -4.07 billion and capital expenditures -228.35 million, giving a free cash flow of -4.29 billion.
| Operating Cash Flow | -4.07B |
| Capital Expenditures | -228.35M |
| Depreciation & Amortization | 672.50M |
| Net Borrowing | -358.91M |
| Free Cash Flow | -4.29B |
| FCF Per Share | -183.40 |
Margins
| Gross Margin | 96.77% |
| Operating Margin | -1,288.55% |
| Pretax Margin | -1,395.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AprilBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.41% |
| Shareholder Yield | -1.41% |
| Earnings Yield | -1.04% |
| FCF Yield | -0.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 31, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Oct 31, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |